{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:44:57Z","timestamp":1791099897838,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T00:00:00Z","timestamp":1171843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T00:00:00Z","timestamp":1171843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.bmt.1705609","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T16:13:02Z","timestamp":1171901582000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors"],"prefix":"10.1038","volume":"39","author":[{"given":"R M","family":"Sobecks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kalaycio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pohlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Theil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Bolwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,19]]},"reference":[{"key":"BF1705609_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995; 332: 217\u2013223.","journal-title":"N Engl J Med"},{"key":"BF1705609_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJM199303043280901","volume":"328","author":"NA Kernan","year":"1993","unstructured":"Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A et al. Analysis of 462 transplantations from unrelated donors facilitated by The National Marrow Donor Program. N Engl J Med 1993; 328: 593\u2013602.","journal-title":"N Engl J Med"},{"key":"BF1705609_CR3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/79526","volume":"6","author":"JJ Molldrem","year":"2000","unstructured":"Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000; 6: 1018\u20131023.","journal-title":"Nat Med"},{"key":"BF1705609_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V67.3.722.722","volume":"67","author":"T Hercend","year":"1986","unstructured":"Hercend T, Takvorian T, Nowill A, Tantravahi R, Moingeon P, Anderson KC et al. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 1986; 67: 722\u2013728.","journal-title":"Blood"},{"key":"BF1705609_CR5","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097\u20132100.","journal-title":"Science"},{"key":"BF1705609_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","volume":"100","author":"S Farag","year":"2002","unstructured":"Farag S, Fehniger T, Ruggeri L, Velardi A, Caligiuri MA . Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935\u20131947.","journal-title":"Blood"},{"key":"BF1705609_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/35642","volume":"391","author":"LL Lanier","year":"1998","unstructured":"Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH . Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391: 703\u2013707.","journal-title":"Nature"},{"key":"BF1705609_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0952-7915(97)80079-9","volume":"9","author":"JC Unkeless","year":"1997","unstructured":"Unkeless JC, Jin J . Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol 1997; 9: 338\u2013343.","journal-title":"Curr Opin Immunol"},{"key":"BF1705609_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1074-7613(00)80616-0","volume":"9","author":"M Vales-Gomez","year":"1998","unstructured":"Vales-Gomez M, Reyburn HT, Mandelboim M, Strominger JL . Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 1998; 9: 337\u2013344.","journal-title":"Immunity"},{"key":"BF1705609_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0161-5890(02)00030-5","volume":"38","author":"JC Boyington","year":"2002","unstructured":"Boyington JC, Sun PD . A structural perspective on MHC class I recognition by killer immunoglobulin-like receptors. Mol Immunol 2002; 38: 1007\u20131021.","journal-title":"Mol Immunol"},{"key":"BF1705609_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1084\/jem.181.3.1133","volume":"181","author":"JE Gumperz","year":"1995","unstructured":"Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P . The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181: 1133\u20131144.","journal-title":"J Exp Med"},{"key":"BF1705609_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","volume":"94","author":"L Ruggeri","year":"1999","unstructured":"Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333\u2013339.","journal-title":"Blood"},{"key":"BF1705609_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","volume":"102","author":"S Giebel","year":"2003","unstructured":"Giebel S, Locatelli FW, Lamparelli T, Velardi A, Davies S, Frumento G et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814\u2013819.","journal-title":"Blood"},{"key":"BF1705609_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","volume":"103","author":"MA Cook","year":"2004","unstructured":"Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521\u20131526.","journal-title":"Blood"},{"key":"BF1705609_CR15","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","volume":"105","author":"KC Hsu","year":"2005","unstructured":"Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K et al. Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes. Blood 2005; 105: 4878\u20134884.","journal-title":"Blood"},{"key":"BF1705609_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1373\/49.4.692","volume":"49","author":"P Paul","year":"2003","unstructured":"Paul P, Apgar J, Ball EJ . HLA-DRB1* intron-primed sequencing for haploid genotyping. Clin Chem 2003; 49: 692\u2013694.","journal-title":"Clin Chem"},{"key":"BF1705609_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1034\/j.1399-0039.2001.057004300.x","volume":"57","author":"P Paul","year":"2001","unstructured":"Paul P, Thomas D, Kawczak P, Good D, Cook DJ, Ball EJ . Resolution of cis-trans ambiguities between HLA-DRB1 alleles using single-strand conformation polymorphisms and sequencing. Tissue Antigens 2001; 57: 300\u2013307.","journal-title":"Tissue Antigens"},{"key":"BF1705609_CR18","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705609_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1182\/blood.V97.5.1196","volume":"97","author":"GB Vogelsang","year":"2001","unstructured":"Vogelsang GB . How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196\u20131201.","journal-title":"Blood"},{"key":"BF1705609_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","volume":"172","author":"W Leung","year":"2004","unstructured":"Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644\u2013650.","journal-title":"J Immunol"},{"key":"BF1705609_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BF1705609_CR22","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462\u20132465.","journal-title":"Blood"},{"key":"BF1705609_CR23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V95.8.2645","volume":"95","author":"DL Porter","year":"2000","unstructured":"Porter DL, Collins Jr RH, Hardy C, Kernan NA, Drobyski WR, Giralt S et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214\u20131221.","journal-title":"Blood"},{"key":"BF1705609_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1200\/JCO.2002.20.2.405","volume":"20","author":"JE Levine","year":"2002","unstructured":"Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol 2002; 20: 405\u2013412.","journal-title":"J Clin Oncol"},{"key":"BF1705609_CR25","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/sj.leu.2403839","volume":"19","author":"S Verheyden","year":"2005","unstructured":"Verheyden S, Schots R, Duquet W, Demanet C . A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after HLA-identical hematopoietic stem cell transplantation. Leukemia 2005; 19: 1446\u20131451.","journal-title":"Leukemia"},{"key":"BF1705609_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.4049\/jimmunol.168.4.1636","volume":"168","author":"H Xu","year":"2002","unstructured":"Xu H, Exner B, Cramer D, Tanner MK, Mueller YM, Ildstad ST . CD8+, \u03b1\u03b2-TCR+, and \u03b3\u03b4-TCR+ cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol 2002; 168: 1636\u20131643.","journal-title":"J Immunol"},{"key":"BF1705609_CR27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.V76.7.1419.1419","volume":"76","author":"P Tiberghien","year":"1990","unstructured":"Tiberghien P, Longo D, Wine J, Alvord WG, Reynolds CW . Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: Evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 1990; 76: 1419\u20131430.","journal-title":"Blood"},{"key":"BF1705609_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri1306","volume":"4","author":"E Vivier","year":"2004","unstructured":"Vivier E, Anfossi N . Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004; 4: 190\u2013198.","journal-title":"Nat Rev Immunol"},{"key":"BF1705609_CR29","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/eji.1830241005","volume":"24","author":"S Ferrini","year":"1994","unstructured":"Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC et al. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 functions. Eur J Immunol 1994; 24: 2294\u20132298.","journal-title":"Eur J Immunol"},{"key":"BF1705609_CR30","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","volume":"174","author":"W Leung","year":"2005","unstructured":"Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540\u20136545.","journal-title":"J Immunol"},{"key":"BF1705609_CR31","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.4049\/jimmunol.166.5.2992","volume":"166","author":"CM Gardiner","year":"2001","unstructured":"Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166: 2992\u20133001.","journal-title":"J Immunol"},{"key":"BF1705609_CR32","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.4049\/jimmunol.169.8.4253","volume":"169","author":"S Santourlidis","year":"2002","unstructured":"Santourlidis S, Trompeter HI, Weinhold S, Eisermann B, Meyer KL, Wernet P et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002; 169: 4253\u20134261.","journal-title":"J Immunol"},{"key":"BF1705609_CR33","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.4049\/jimmunol.168.5.2307","volume":"168","author":"HG Shilling","year":"2002","unstructured":"Shilling HG, Guethlein LA, Cheng CM, Gardiner CM, Rodriguez R, Tyan D et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002; 168: 2307\u20132315.","journal-title":"J Immunol"},{"key":"BF1705609_CR34","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.4049\/jimmunol.171.4.1768","volume":"171","author":"JP Goodridge","year":"2003","unstructured":"Goodridge JP, Witt CS, Christiansen FT, Warren HS . KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003; 171: 1768\u20131774.","journal-title":"J Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705609","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:29:53Z","timestamp":1648081793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,19]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BF1705609"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705609","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,19]]},"assertion":[{"value":"27 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}